Loading organizations...
Loading organizations...
DoubleRainbow Biosciences: Biotech company developing natural product therapeutics & nutraceuticals for healthcare, focused on oncology.
DoubleRainbow Biosciences is a Lexington, Massachusetts-based biotechnology company that develops novel therapeutics and nutraceuticals by leveraging genomics, metabolomics, and synthetic biology. The organization utilizes precision glycosylation and enzyme modification platforms to bioengineer natural products into more soluble and potent compounds for oncology and broader healthcare applications. Operating with an internal team of over 20 employees, the enterprise has filed three patents to protect its proprietary molecular biosynthesis technologies and advance two drug discovery platforms toward preclinical development. The venture has raised $26 million in total equity funding across multiple financing rounds, securing capital from notable institutional and corporate investors including Betta Pharmaceuticals, Oriza Ventures, and Gaorong Capital. Following their academic research at the Massachusetts Institute of Technology and Yale University, the commercial biotechnology enterprise was officially founded in 2017 by Jing-Ke Weng and Tian Xu.
DoubleRainbow Biosciences has raised $10.0M across 1 funding round.
DoubleRainbow Biosciences has raised $10.0M in total across 1 funding round.
DoubleRainbow Biosciences has raised $10.0M in total across 1 funding round.
DoubleRainbow Biosciences's investors include Betta Pharmaceuticals.
DoubleRainbow Biosciences has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series B in August 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 10, 2021 | $10.0M Series B | Betta Pharmaceuticals |